SCHEMBL23158609

SCHEMBL23158609

CC(C)[C@H](NC(=O)OC(C)(C)C)C(=O)NCCOC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TTR P02766 2/20 0.50
▸ CYP2C9 P11712 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ USP2 O75604 1/20 0.50
▸ LMNA P02545 1/20 0.50
▸ TBXA2R P21731 1/20 0.50
▸ MAPK1 P28482 1/20 0.50
▸ PTGS2 P35354 4/20 0.45
▸ PTGS1 P23219 2/20 0.43
▸ CXCL8 P10145 2/20 0.43
▸ AKR1B10 O60218 1/20 0.43
▸ UGT1A9 O60656 1/20 0.43
▸ TRPA1 O75762 1/20 0.43
▸ ABCB11 O95342 1/20 0.43
▸ MT-CO2 P00403 1/20 0.43
▸ ALB P02768 1/20 0.43
▸ UGT1A6 P19224 1/20 0.43
▸ UGT1A1 P22309 1/20 0.43
▸ CXCR1 P25024 1/20 0.43
▸ ADRA1A P35348 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23158592 0.91 TTR (0.54) TTRCYP2C9KMT2AUSP2LMNA
SCHEMBL23158632 0.88 TTR (0.50) TTRCYP2C9KMT2AUSP2LMNA
SCHEMBL23177649 0.88 TTR (0.50) TTRCYP2C9KMT2AUSP2LMNA
SCHEMBL17001513 0.87 TTR (0.59) TTRCYP2C9KMT2AUSP2LMNA
SCHEMBL23158577 0.86 CTSS (0.51) TTRCYP2C9KMT2AUSP2LMNA
SCHEMBL23158797 0.84 TTR (0.46) TTRCYP2C9KMT2AUSP2LMNA
SCHEMBL23177646 0.83 TTR (0.45) TTRCYP2C9KMT2AUSP2LMNA
SCHEMBL23158581 0.83 TTR (0.45) TTRCYP2C9KMT2AUSP2LMNA
SCHEMBL23158657 0.83 TTR (0.41) TTRCYP2C9KMT2AUSP2LMNA
SCHEMBL23177946 0.83 TTR (0.41) TTRCYP2C9KMT2AUSP2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021060351-A1 NSAID-BONDED ALGINIC ACID DERIVATIVE 持田製薬株式会社 2021-04-01 — — WO disclosed
WO-2021060395-A1 SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITION 持田製薬株式会社 2021-04-01 — — WO disclosed
Send feedback